Regencell Bioscience Holdings Ltd Quarterly Operating Lease, Liability, Current in USD from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Regencell Bioscience Holdings Ltd quarterly Operating Lease, Liability, Current history and growth rate from Q2 2022 to Q2 2024.
  • Regencell Bioscience Holdings Ltd Operating Lease, Liability, Current for the quarter ending June 30, 2024 was $59.8K, a 86.4% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $59.8K -$378K -86.4% Jun 30, 2024 20-F 2024-10-25
Q2 2023 $438K +$27.3K +6.64% Jun 30, 2023 20-F 2024-10-25
Q2 2022 $411K Jun 30, 2022 20-F 2023-10-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.